{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:05:49Z","timestamp":1787940349595,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1P50HD103537"],"award-info":[{"award-number":["1P50HD103537"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH112485"],"award-info":[{"award-number":["T32MH112485"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10803-024-06249-x","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T04:07:00Z","timestamp":1708574820000},"page":"4160-4166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Symptoms of Catatonia Observed in Down Syndrome Regressive Disorder: A Retrospective Analysis"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-165X","authenticated-orcid":false,"given":"Joshua R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seri","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Luccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"6249_CR1","unstructured":"Akhtar, F., & Bokhari, S. R. A. (2023). Down Syndrome. In StatPearls. StatPearls Publishing. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526016\/"},{"issue":"1","key":"6249_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12929-015-0138-y","volume":"22","author":"A Asim","year":"2015","unstructured":"Asim, A., Kumar, A., Muthuswamy, S., Jain, S., & Agarwal, S. (2015). Down syndrome: An insight of the disease. Journal of Biomedical Science, 22(1), 41. https:\/\/doi.org\/10.1186\/s12929-015-0138-y","journal-title":"Journal of Biomedical Science"},{"issue":"5","key":"6249_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.psym.2020.04.015","volume":"61","author":"JE Becker","year":"2020","unstructured":"Becker, J. E., Smith, J. R., & Hazen, E. P. (2020). Pediatric consultation-liaison psychiatry: An update and review. Psychosomatics, 61(5), 467\u2013480. https:\/\/doi.org\/10.1016\/j.psym.2020.04.015","journal-title":"Psychosomatics"},{"issue":"2\u20133","key":"6249_CR4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.schres.2016.06.020","volume":"176","author":"X Benarous","year":"2016","unstructured":"Benarous, X., Consoli, A., Raffin, M., Bodeau, N., Giannitelli, M., Cohen, D., & Olliac, B. (2016). Validation of the pediatric catatonia rating scale (PCRS). Schizophrenia Research, 176(2\u20133), 378\u2013386. https:\/\/doi.org\/10.1016\/j.schres.2016.06.020","journal-title":"Schizophrenia Research"},{"key":"6249_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.schres.2017.07.028","volume":"200","author":"X Benarous","year":"2018","unstructured":"Benarous, X., Raffin, M., Ferrafiat, V., Consoli, A., & Cohen, D. (2018). Catatonia in children and adolescents: New perspectives. Schizophrenia Research, 200, 56\u201367. https:\/\/doi.org\/10.1016\/j.schres.2017.07.028","journal-title":"Schizophrenia Research"},{"key":"6249_CR6","doi-asserted-by":"publisher","first-page":"1126973","DOI":"10.3389\/fnins.2023.1126973","volume":"17","author":"S Bonne","year":"2023","unstructured":"Bonne, S., Iftimovici, A., Mircher, C., Conte, M., Louveau, C., Legrand, A., Danset-Alexandre, C., Cannarsa, C., Debril, A., Consoli, A., Krebs, M.-O., Ellul, P., & Chaumette, B. (2023). Down syndrome regression disorder, a case series: Clinical characterization and therapeutic approaches. Frontiers in Neuroscience, 17, 1126973. https:\/\/doi.org\/10.3389\/fnins.2023.1126973","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"6249_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-0447.1996.tb09814.x","volume":"93","author":"G Bush","year":"1996","unstructured":"Bush, G., Fink, M., Petrides, G., Dowling, F., & Francis, A. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93(2), 129\u2013136. https:\/\/doi.org\/10.1111\/j.1600-0447.1996.tb09814.x","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"6249_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00004714-198312000-00002","volume":"3","author":"GL Fricchione","year":"1983","unstructured":"Fricchione, G. L., Cassem, N. H., Hooberman, D., & Hobson, D. (1983). Intravenous lorazepam in neuroleptic-indueed catatonia. Journal of Clinical Psychopharmacology, 3(6), 338\u2013342.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"6249_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2147\/NDT.S77307","volume":"11","author":"N Ghaziuddin","year":"2015","unstructured":"Ghaziuddin, N., Nassiri, A., & Miles, J. H. (2015). Catatonia in Down syndrome; a treatable cause of regression. Neuropsychiatric Disease and Treatment, 11, 941\u2013949. https:\/\/doi.org\/10.2147\/NDT.S77307","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"3","key":"6249_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S2215-0366(22)00436-9","volume":"10","author":"AJ Hauptman","year":"2023","unstructured":"Hauptman, A. J., Cohen, D., Dhossche, D., Raffin, M., Wachtel, L., & Ferrafiat, V. (2023). Catatonia in neurodevelopmental disorders: Assessing catatonic deterioration from baseline. The Lancet Psychiatry, 10(3), 228\u2013234. https:\/\/doi.org\/10.1016\/S2215-0366(22)00436-9","journal-title":"The Lancet Psychiatry"},{"issue":"19","key":"6249_CR11","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJMra2116304","volume":"389","author":"S Heckers","year":"2023","unstructured":"Heckers, S., & Walther, S. (2023). Catatonia. The New England Journal of Medicine, 389(19), 1797\u20131802. https:\/\/doi.org\/10.1056\/NEJMra2116304","journal-title":"The New England Journal of Medicine"},{"issue":"23","key":"6249_CR12","doi-asserted-by":"publisher","first-page":"00057","DOI":"10.1016\/j.schres.2023.02.015","volume":"S0920\u20139964","author":"D Hirjak","year":"2023","unstructured":"Hirjak, D., Fricchione, G., Wolf, R. C., & Northoff, G. (2023). Lorazepam in catatonia\u2014Past, present and future of a clinical success story. Schizophrenia Research, S0920\u20139964(23), 00057\u201300059. https:\/\/doi.org\/10.1016\/j.schres.2023.02.015","journal-title":"Schizophrenia Research"},{"key":"6249_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.schres.2023.09.011","volume":"261","author":"B Jakubowicz","year":"2023","unstructured":"Jakubowicz, B., Baptista, A., Ravel, A., Cieuta, C., Mircher, C., Cohen, D., Consoli, A., & Raffin, M. (2023). Catatonia in Down\u2019s syndrome: An under-recognized syndrome during regression. Schizophrenia Research, 261, 107\u2013109. https:\/\/doi.org\/10.1016\/j.schres.2023.09.011","journal-title":"Schizophrenia Research"},{"issue":"4","key":"6249_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/YCT.0b013e31821d37c6","volume":"27","author":"SN Jap","year":"2011","unstructured":"Jap, S. N., & Ghaziuddin, N. (2011). Catatonia among adolescents with Down syndrome: A review and 2 case reports. The Journal of ECT, 27(4), 334\u2013337. https:\/\/doi.org\/10.1097\/YCT.0b013e31821d37c6","journal-title":"The Journal of ECT"},{"key":"6249_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.schres.2022.01.038","volume":"241","author":"J Luccarelli","year":"2022","unstructured":"Luccarelli, J., Fricchione, G., Newton, A. W., & Wozniak, J. (2022a). The diagnosis and treatment of catatonia via telemedicine: A case report and proposed diagnostic criteria. Schizophrenia Research, 241, 66\u201367. https:\/\/doi.org\/10.1016\/j.schres.2022.01.038","journal-title":"Schizophrenia Research"},{"key":"6249_CR16","doi-asserted-by":"publisher","first-page":"878173","DOI":"10.3389\/fpsyt.2022.878173","volume":"13","author":"J Luccarelli","year":"2022","unstructured":"Luccarelli, J., Kalinich, M., Fernandez-Robles, C., Fricchione, G., & Beach, S. R. (2022b). The incidence of catatonia diagnosis among pediatric patients discharged from general hospitals in the United States: A kids\u2019 inpatient database study. Frontiers in Psychiatry, 13, 878173. https:\/\/doi.org\/10.3389\/fpsyt.2022.878173","journal-title":"Frontiers in Psychiatry"},{"issue":"7951","key":"6249_CR17","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1038\/s41586-023-05736-y","volume":"615","author":"L Malle","year":"2023","unstructured":"Malle, L., Patel, R. S., Martin-Fernandez, M., Stewart, O. J., Philippot, Q., Buta, S., Richardson, A., Barcessat, V., Taft, J., Bastard, P., Samuels, J., Mircher, C., Rebillat, A.-S., Maillebouis, L., Vilaire-Meunier, M., Tuballes, K., Rosenberg, B. R., Trachtman, R., Casanova, J.-L., & Bogunovic, D. (2023). Autoimmunity in Down\u2019s syndrome via cytokines, CD4 T cells and CD11c+ B cells. Nature, 615(7951), 7951. https:\/\/doi.org\/10.1038\/s41586-023-05736-y","journal-title":"Nature"},{"key":"6249_CR18","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.2147\/NDT.S210613","volume":"15","author":"JH Miles","year":"2019","unstructured":"Miles, J. H., Takahashi, N., Muckerman, J., Nowell, K. P., & Ithman, M. (2019). Catatonia in Down syndrome: Systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients. Neuropsychiatric Disease and Treatment, 15, 2723\u20132741. https:\/\/doi.org\/10.2147\/NDT.S210613","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"3","key":"6249_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jaac.2022.07.850","volume":"62","author":"M Ong","year":"2023","unstructured":"Ong, M., Patterson, E., Stewart, L., Pierce, D., & Smith, J. R. (2023). Morbidity due to disparity in pediatric electroconvulsive therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 62(3), 279\u2013281. https:\/\/doi.org\/10.1016\/j.jaac.2022.07.850","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"6249_CR20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jaac.2018.03.020","volume":"57","author":"M Raffin","year":"2018","unstructured":"Raffin, M., Consoli, A., Giannitelli, M., Philippe, A., Keren, B., Bodeau, N., Levinson, D. F., Cohen, D., & Laurent-Levinson, C. (2018). Catatonia in children and adolescents: a high rate of genetic conditions. Journal of the American Academy of Child & Adolescent Psychiatry, 57(7), 518-525.e1. https:\/\/doi.org\/10.1016\/j.jaac.2018.03.020","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"4","key":"6249_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/02698811231158232","volume":"37","author":"JP Rogers","year":"2023","unstructured":"Rogers, J. P., Oldham, M. A., Fricchione, G., Northoff, G., Ellen Wilson, J., Mann, S. C., Francis, A., Wieck, A., Elizabeth Wachtel, L., Lewis, G., Grover, S., Hirjak, D., Ahuja, N., Zandi, M. S., Young, A. H., Fone, K., Andrews, S., Kessler, D., Saifee, T., & David, A. S. (2023). Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology (Oxford, England), 37(4), 327\u2013369. https:\/\/doi.org\/10.1177\/02698811231158232","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"6","key":"6249_CR22","doi-asserted-by":"publisher","first-page":"e20192939","DOI":"10.1542\/peds.2019-2939","volume":"145","author":"M Rosso","year":"2020","unstructured":"Rosso, M., Fremion, E., Santoro, S. L., Oreskovic, N. M., Chitnis, T., Skotko, B. G., & Santoro, J. D. (2020). Down syndrome disintegrative disorder: A clinical regression syndrome of increasing importance. Pediatrics, 145(6), e20192939. https:\/\/doi.org\/10.1542\/peds.2019-2939","journal-title":"Pediatrics"},{"key":"6249_CR23","doi-asserted-by":"publisher","unstructured":"Santoro, J., Spinazzi, N., Filipink, R., Hayati-Rezvan, P., Kammeyer, R., Patel, L., Sannar, E., Dwyer, L., Banerjee, A., Khoshnood, M., Jafarpour, S., Boyd, N., Partridge, R., Gombolay, G., Christy, A., Real de Asua, D., Del Carmen Ortega, M., Manning, M., Van Mater, H., Rafii, M. (2023). Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder. Research Square, rs.3.rs-2521595. https:\/\/doi.org\/10.21203\/rs.3.rs-2521595\/v1","DOI":"10.21203\/rs.3.rs-2521595\/v1"},{"issue":"1","key":"6249_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s11689-022-09446-w","volume":"14","author":"JD Santoro","year":"2022","unstructured":"Santoro, J. D., Partridge, R., Tanna, R., Pagarkar, D., Khoshnood, M., Rehmani, M., Kammeyer, R. M., Gombolay, G. Y., Fisher, K., Conravey, A., El-Dahr, J., Christy, A. L., Patel, L., Manning, M. A., Van Mater, H., Rafii, M. S., & Quinn, E. A. (2022a). Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder. Journal of Neurodevelopmental Disorders, 14(1), 35. https:\/\/doi.org\/10.1186\/s11689-022-09446-w","journal-title":"Journal of Neurodevelopmental Disorders"},{"key":"6249_CR25","doi-asserted-by":"publisher","first-page":"940175","DOI":"10.3389\/fneur.2022.940175","volume":"13","author":"JD Santoro","year":"2022","unstructured":"Santoro, J. D., Patel, L., Kammeyer, R., Filipink, R. A., Gombolay, G. Y., Cardinale, K. M., Real de Asua, D., Zaman, S., Santoro, S. L., Marzouk, S. M., Khoshnood, M., Vogel, B. N., Tanna, R., Pagarkar, D., Dhanani, S., Ortega, M. D. C., Partridge, R., Stanley, M. A., Sanders, J. S., & Rafii, M. S. (2022). Assessment and diagnosis of down syndrome regression disorder: International expert consensus. Frontiers in Neurology, 13, 940175. https:\/\/doi.org\/10.3389\/fneur.2022.940175","journal-title":"Frontiers in Neurology"},{"key":"6249_CR26","doi-asserted-by":"publisher","first-page":"1208926","DOI":"10.3389\/frcha.2023.1208926","volume":"2","author":"JR Smith","year":"2023","unstructured":"Smith, J. R., Baldwin, I., York, T., Anderson, C., McGonigle, T., Vandekar, S., Wachtel, L., & Luccarelli, J. (2023a). Alternative psychopharmacologic treatments for pediatric catatonia: A retrospective analysis. Frontiers in Child and Adolescent Psychiatry, 2, 1208926. https:\/\/doi.org\/10.3389\/frcha.2023.1208926","journal-title":"Frontiers in Child and Adolescent Psychiatry"},{"key":"6249_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-022-05868-6","author":"JR Smith","year":"2022","unstructured":"Smith, J. R., Hopkins, C. E., Xiong, J., Luccarelli, J., Shultz, E., & Vandekar, S. (2022). Use of ECT in autism spectrum disorder and\/or intellectual disability: A single site retrospective analysis. Journal of Autism and Developmental Disorders. https:\/\/doi.org\/10.1007\/s10803-022-05868-6","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"3","key":"6249_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/cap.2022.0067","volume":"33","author":"JR Smith","year":"2023","unstructured":"Smith, J. R., York, T., Warn, S., Borodge, D., Pierce, D. L., & Fuchs, D. C. (2023b). Another option for aggression and self-injury, alternative benzodiazepines for catatonia in profound autism. Journal of Child and Adolescent Psychopharmacology, 33(3), 109\u2013117. https:\/\/doi.org\/10.1089\/cap.2022.0067","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"10","key":"6249_CR29","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/0004867420968915","volume":"55","author":"HH Suchandra","year":"2021","unstructured":"Suchandra, H. H., Reddi, V. S. K., Aandi Subramaniyam, B., & Muliyala, K. P. (2021). Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting. The Australian and New Zealand Journal of Psychiatry, 55(10), 993\u20131004. https:\/\/doi.org\/10.1177\/0004867420968915","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"issue":"4","key":"6249_CR30","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/YCT.0000000000000116","volume":"30","author":"J Torr","year":"2014","unstructured":"Torr, J., & D\u2019Abrera, J. C. (2014). Maintenance electroconvulsive therapy for depression with catatonia in a young woman with Down syndrome. The Journal of ECT, 30(4), 332\u2013336. https:\/\/doi.org\/10.1097\/YCT.0000000000000116","journal-title":"The Journal of ECT"},{"issue":"1","key":"6249_CR31","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2259","volume":"65","author":"J Vaquerizo-Serrano","year":"2022","unstructured":"Vaquerizo-Serrano, J., Salazar De Pablo, G., Singh, J., & Santosh, P. (2022). Catatonia in autism spectrum disorders: A systematic review and meta-analysis. European Psychiatry, 65(1), e4. https:\/\/doi.org\/10.1192\/j.eurpsy.2021.2259","journal-title":"European Psychiatry"},{"issue":"9","key":"6249_CR32","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/brainsci11091197","volume":"11","author":"M Walpert","year":"2021","unstructured":"Walpert, M., Zaman, S., & Holland, A. (2021). A systematic review of unexplained early regression in adolescents and adults with down syndrome. Brain Sciences, 11(9), 1197. https:\/\/doi.org\/10.3390\/brainsci11091197","journal-title":"Brain Sciences"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-024-06249-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-024-06249-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-024-06249-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:25:24Z","timestamp":1761823524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10803-024-06249-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6249"],"URL":"https:\/\/doi.org\/10.1007\/s10803-024-06249-x","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"13 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JRS receives funding from Roche, Axial Therapeutics, and the National Institute of Child and Human Development. JL receives funding from Harvard Medical School Dupont Warren Fellowship and Livingston Awards, the Rappaport Foundation, and the Foundation for Prader-Willi Research. He has received equity and consulting fees from Revival Therapeutics, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We received institutional review board approval from Vanderbilt University Medical Center to waive consent and review, analyze, and report anonymously on these patients (IRB Number: 230097).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}